Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.40 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.40 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.40 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | KDM4C | Q9H3R0 | 9/20 | 0.39 |
| ▸ | KDM5A | P29375 | 7/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.32 |
| ▸ | FDPS | P14324 | 1/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.32 |
| ▸ | KDM4A | O75164 | 2/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16475529 | 1.00 | EPHX1 (0.44) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL22343848 | 0.98 | EPHX1 (0.46) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL19245115 | 0.95 | EPHX1 (0.50) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL22564674 | 0.95 | EPHX1 (0.50) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL17001500 | 0.95 | EPHX1 (0.50) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL25004071 | 0.91 | PRMT3 (0.40) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL3316663 | 0.90 | — | — | |
| SCHEMBL25075475 | 0.90 | PRMT3 (0.48) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL22946807 | 0.87 | EPHX1 (0.50) | EPHX1PRMT3CARM1PRMT6PRMT1 | |
| SCHEMBL13540767 | 0.87 | PRMT3 (0.46) | EPHX1PRMT3CARM1PRMT6PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170065541-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-03-09 | — | — | US | disclosed |
| US-9458100-B2 | Synthesis and growth regulatory activity of a prototype member of a new family of aminothiol radioprotectors | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-10-04 | — | — | US | disclosed |
| US-20160243062-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-08-25 | — | — | US | disclosed |
| US-20140107216-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2014-04-17 | — | — | US | disclosed |
| US-20140107217-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2014-04-17 | — | — | US | disclosed |
| US-20090124832-A1 | OLIGOAMINE COMPOUNDS AND DERIVATIVES THEREOF FOR CANCER THERAPY | PROGEN PHARMACEUTICALS, INC. (US) | 2009-05-14 | — | — | US | disclosed |
| US-7491849-B2 | Oligoamine compounds and derivatives thereof for cancer therapy | PROGEN PHARMACEUTICALS, INC. (US) | 2009-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140107216-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS | ROS1, PRMT1, MCL1 | EPHX1 3166/4885PRMT3 4/4885CARM1 119/4885 |
| US-20170065541-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS | ROS1, PRMT1, RNF10 | EPHX1 4337/4885PRMT3 5/4885CARM1 388/4885 |
| US-20090124832-A1 | OLIGOAMINE COMPOUNDS AND DERIVATIVES THEREOF FOR CANCER THERAPY | THOP1, OAT, DUT | EPHX1 4519/4885PRMT3 2770/4885CARM1 2440/4885 |
| US-20140107217-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMlNOTHIOL RADIOPROTECTORS | ROS1, PRMT1, MCL1 | EPHX1 3166/4885PRMT3 4/4885CARM1 119/4885 |
| US-20160243062-A1 | SYNTHESIS AND GROWTH REGULATORY ACTIVITY OF A PROTOTYPE MEMBER OF A NEW FAMILY OF AMINOTHIOL RADIOPROTECTORS | ROS1, RNF10, PRMT1 | EPHX1 4398/4885PRMT3 4/4885CARM1 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.